Evidence map›Paper›PMID 18222148›Full record

ReviewSeminars in oncology nursing2008

Smoking cessation and lung cancer: oncology nurses can make a difference.

Mary E Cooley, Rebecca L Sipples, Meagan Murphy, Linda Sarna

Open access · bronzeAbstract readReview
In one paragraph

Review in Seminars in oncology nursing, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Does Quitting Smoking Make a Difference Among Newly Diagnosed Head and Neck Cancer Patients?Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2016
    Observational
  12. Article
  13. Review
  14. Current and emerging pharmacotherapeutic options for smoking cessation.Substance abuse : research and treatment · 2013
    Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Mary E CooleyCantor Center, Research in Nursing and Patient Care Services, Dana-Farber Cancer Institute, Boston, MA 02115, USA. mary_cooley@dfci.harvard.edu
Rebecca L Sipples
Meagan Murphy
Linda Sarna
Yale Cancer Center · USDana-Farber Cancer Institute · USYale University · US

Funding

Behavioral Oncology Career DevelopmentK07CA095118 · NCI · DANA-FARBER CANCER INSTITUTE · PI COOLEY, MARY E · 2003 to 2007
$679k
NCI NIH HHS 1 K07 CA92692NCI NIH HHS K07 CA095118
6 · The paper itself

Abstract

objectivesTo provide an overview of the impact of smoking after a diagnosis of lung cancer, discuss the relationship between smoking cessation and improved outcomes, present information about tobacco-dependence treatments, reimbursement for these treatments, and resources available for patients and health care professionals. DATA SOURCES: Published articles, reports, websites, and research studies.

conclusionPrevention of tobacco use and cessation are primary ways to prevent lung cancer. However, even after a diagnosis of lung cancer, smoking cessation is important in improving survival and quality of life. Although effective treatments are available to help smokers quit, persistent efforts over repeated contacts may be necessary to achieve long-term cessation. IMPLICATIONS FOR NURSING PRACTICE: Oncology nursing action is essential in the identification of and intervention with patients who struggle with tobacco dependence after diagnosis.

Indexed as

BenzazepinesBupropionDopamine Uptake InhibitorsHumansInformation ServicesLung NeoplasmsNicotineOncology NursingQuinoxalinesSmokingSmoking CessationVareniclineBenzazepinesBupropionDopamine Uptake InhibitorsNicotineQuinoxalinesVarenicline

Identifiers

PMID18222148
PMCPMC2249620
OpenAlexW2094328440

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.